andexxa
Generic: andexanet alfa
Labeler: astrazeneca pharmaceuticals lpDrug Facts
Product Profile
Brand Name
andexxa
Generic Name
andexanet alfa
Labeler
astrazeneca pharmaceuticals lp
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
andexanet alfa 200 mg/20mL
Manufacturer
Identifiers & Regulatory
Product NDC
0310-3200
Product ID
0310-3200_d77f3b2f-eda8-45ae-8455-0fc1694fcd54
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA125586
Listing Expiration
2026-12-31
Marketing Start
2022-07-12
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03103200
Hyphenated Format
0310-3200
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
andexxa (source: ndc)
Generic Name
andexanet alfa (source: ndc)
Application Number
BLA125586 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/20mL
Packaging
- 4 VIAL, SINGLE-USE in 1 CARTON (0310-3200-04) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)
- 5 VIAL, SINGLE-USE in 1 CARTON (0310-3200-05) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d77f3b2f-eda8-45ae-8455-0fc1694fcd54", "openfda": {"unii": ["BI009E452R"], "rxcui": ["2108128", "2108130"], "spl_set_id": ["2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL, SINGLE-USE in 1 CARTON (0310-3200-04) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)", "package_ndc": "0310-3200-04", "marketing_start_date": "20220712"}, {"sample": false, "description": "5 VIAL, SINGLE-USE in 1 CARTON (0310-3200-05) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)", "package_ndc": "0310-3200-05", "marketing_start_date": "20230703"}], "brand_name": "ANDEXXA", "product_id": "0310-3200_d77f3b2f-eda8-45ae-8455-0fc1694fcd54", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "0310-3200", "generic_name": "andexanet alfa", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ANDEXXA", "active_ingredients": [{"name": "ANDEXANET ALFA", "strength": "200 mg/20mL"}], "application_number": "BLA125586", "marketing_category": "BLA", "marketing_start_date": "20220712", "listing_expiration_date": "20261231"}